Skip to main content

Table 2 Geometric mean thymine glycol (d(TgpA)), formamide (d(PfpA)) and 8-oxo-7,8-dihydroguanine (dGh) lesions (fmol/μg) by week, unadjusted and adjusted for age, gender, and treatment condition

From: Reduction in oxidatively generated DNA damage following smoking cessation

Sample (N)

% abstinent

Cigarette per week (SEM)

d(TgpA) fmol/μg (SEM)

d(PfpA) fmol/μg (SEM)

dGhfmol/μg (SEM)

   

Unadj

Adj

Unadj

Adj

Unadj

Adj

TQD - 4 weeks [baseline] (N = 19)

0

126 (7.5)

0.89 (1.15)

1.06 (0.15)

1.77 (1.13)

1.93 (0.20)

31.70 (1.12)

33.15 (2.49)

TQD [week 0] (N = 19)

68.4

85 (8.7)

0.55 (1.19)

0.71 (0.10)

1.51 (1.09)

1.55 (0.12)

21.97 (1.07)

21.48 (1.68)

TQD + 4 weeks [week 4] (N = 13)

100

0

0.57 (1.17)

0.64 (0.09)

1.07 (1.14)

1.12 (0.17)

16.40 (1.11)

15.76 (1.65)

TQD +11 [week 11] (N = 10)

100

0

0.81 (1.18)

0.91 (0.13)

1.25 (1.13)

1.23 (0.14)

15.56 (1.15)

15.43 (2.60)

  1. NOTE: Abstinence defined by exhaled breath CO ≤ 8 ppm. Adjusted means are from GEE model including only those cases reporting no cigarettes smoked in the past week and showing CO-confirmed abstinence and controlling for treatment condition, gender, and age. TQD, target quit date.